Pharmacology Flashcards
(47 cards)
Dihydropyridine used in subarachnoid hemorrhage to prevent cerebral vasospasm
Nimodipine
Calcium channel blocker that can cause hyperprolactinemia
Verapamil
Secondary messenger elevated by hydralazine
cGMP
Type of vessel that is predominantly dilated by hydralazine
Arterioles
Antihypertensive that can cause cyanide toxicity
Nitroprusside
Type of vessel that is predominantly dilated by nitroprusside
Both venous and arterial dilator
Mechanism through which nitroprusside increases cGMP
Direct release of nitric oxide
Type of vessel that is predominantly dilated by nitrates (eg, nitroglycerin, isosorbide dinitrate, isosorbide mononitrate)
Veins
Antihypertensives that develop tolerance
Nitrates
Nitrates are contraindicated in which type of infarction
Right ventricular infarction
Mechanism of action of ranolazine
Inhibits the late phase of sodium current (reducing calcium accumulation), thereby reducing diastolic wall tension (for coronary flow) and oxygen consumption
Drug used in drug resistant angina
Ranolazine
Mechanism of action of milrinone and inamrinone
Selective PDE-3 inhibitors
Mechanism of action of neprilysin inhibitors
Prevent degradation of ANP
Bile acid resins (eg, cholestyramine, colestipol, colesevelam) are contraindicated in patients with which type of hyperlipidemia
Hypertriglyceridemia
Hypolipidemic drug that inhibits NPC1L1, thereby preventing colesterol absorption
Ezetimibe
DOC for patients with hypertriglyceridemia
Fibrates (eg, gemfibrozil, bezafibrate, fenofibrate)
Mechanism of action of fibrates
- Upregulate LPL to increase TG clearance
* Activate PPAR alpha to induce HDL synthesis
Adverse effects of fibrates
- Myopathy (increased risk with statins)
* Cholesterol gallstones
Mechanism of action of niacin
- Inhibit hormone-sensitive lipase in adipose tissue
* Reduces hepatic VLDL synthesis
Mechanism of action of PCSK9 inhibitors (eg, alirocumab, evolocumab)
Inactivation of LDL receptor degradation, increasing amount of LDL removed from bloodstream
Hypolipidemic drugs that have neurocognitive effects
PCSK9 inhibitors
How does cardiac glycosides decrease heart rate
Stimulation of the vagus nerve
Clinical use of cardiac glycosides
- HF (increase contractility)
* Atrial fibrillation (decreased conduction at AV node and depression of SA node)